Global Epigenetics Market Analysis Report 2022: Growing Prevalence of Cancer and Other Diseases Significantly Driving Growth

DUBLIN, Dec. 1, 2022 /PRNewswire/ -- The "Epigenetics Global Market Report 2022" report has been added to  ResearchAndMarkets.com's offering.

The global epigenetics market is expected to grow from $6.15 billion in 2021 to $7.33 billion in 2022 at a compound annual growth rate (CAGR) of 19.18%. The epigenetics market is expected to grow to $14.79 billion in 2026 at a compound annual growth rate (CAGR) of 19.17%.

The growing prevalence of cancer and other diseases is significantly driving the growth of the epigenetics market. The rising prevalence of diseases increases the demand for epigenetics. According to the European Commission's Joint Research Centre from Ispra, the number of new cancer cases in the European Union (EU) and European Free Trade Association (EFTA) countries will rise by 21.4%, from 2.8 million in 2020 to 3.4 million in 2040.

North America was the largest region in the epigenetics market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Furthermore, according to the Centers for Disease Control and Prevention (CDC), approximately 659,000 people in the United States die of heart disease each year. The increasing prevalence of cancer and other diseases requires testing and knowing the modifications that happened in the genes, which will invariably increase the usage and demand of epigenetics. Thus, the growing prevalence of cancer and other diseases drives the epigenetics market in the coming years.

Technological advancement is the key trend in the epigenetics market. The key players in the epigenetics sector are focusing on developing various technologically advanced products and services to strengthen their position in the market. For instance, in April 2019, Greenwood Genetic Center, a genetic testing services organization based in the United States, in collaboration with the London Health Sciences Centre (LHSC), launched EpiSign, a new diagnostic test centered on disease-specific epigenetic signatures.

The EpiSign test, which is performed on a peripheral blood sample, analyses the genome's DNA methylation patterns to demonstrate a diagnosis or help to resolve variants of uncertain significance (VUS) discovered through DNA testing.

In December 2020, Exact Sciences, a US-based molecular diagnostic company, acquired Base Genomics for $140 million. As a result of this acquisition, Exact Sciences aims to create a multi-cancer early detection blood test. This acquisition also aids in the acceleration of clinical and commercial development. Base Genomics is a UK-based epigenetics company working on designing a blood test for minimal residual disease and early-stage cancer.

The countries covered in the epigenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Major players in the epigenetics market are

• Illumina
• Thermo Fisher Scientific
• Merck Millipore
• Abcam
• Active Motif
• Bio-Rad
• New England Biolabs
• Agilent
• Qiagen
• Zymo Research
• Perkinelmer
• Diagenode
• Hoffmann-La Roche Ltd
• Eisai Co Ltd
• Novartis AG

Key Topics Covered:

1. Executive Summary

2. Epigenetics Market Characteristics

3. Epigenetics Market Trends And Strategies

4. Impact Of COVID-19 On Epigenetics

5. Epigenetics Market Size And Growth
5.1. Global Epigenetics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Epigenetics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Epigenetics Market Segmentation
6.1. Global Epigenetics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Reagents
• Enzymes
• Instruments
• Kits

6.2. Global Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large Noncoding RNA
• MicroRNA Modification
• Chromatin Structures

6.3. Global Epigenetics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Oncology
• Metabolic Diseases
• Developmental Biology
• Immunology
• Cardiovascular Diseases
• Other Applications

6.4. Global Epigenetics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Contract Research Organisations
• Other End Users

7. Epigenetics Market Regional And Country Analysis
7.1. Global Epigenetics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Epigenetics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/1b2cqt

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

SOURCE Research and Markets